Gastrointestinal effects of GLP-1 receptor agonism — nausea in particular — are strongest when exposure increases and tend to diminish with continued exposure at a given level. Starting at the target dose would produce more severe early events and more early discontinuation. Staged increases are the standard approach across the class and were used in both phase 2 trials.
The schedules differed between groups and between the two trials and are given in the papers. They are design parameters, not recommendations, and this page does not reproduce the quantities.
A participant in the highest group spent the first part of the trial at lower exposures. Weight and glucose changes in that period therefore understate what the target dose produces, and the full-dose period is shorter than the trial length. A 48-week result for the highest group reflects less than 48 weeks at target.
This also means early adverse-event rates are a mixture across exposures rather than a property of the labelled dose.
Trials with different escalation schedules are not comparable at early time points even for the same molecule. Across molecules, differing schedules are one more reason headline figures from separate trials cannot be set side by side.
Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.
| Format | Strength | Price | Availability |
|---|---|---|---|
| Retatrutide Pack | 20 mg | AED 1010 | In stock |
Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.
Gastrointestinal effects of GLP-1 receptor agonism — nausea in particular — are strongest when exposure increases and tend to diminish with continued exposure at a given level. Starting at the target dose would produce more severe early events and more early discontinuation. Staged increases are the standard approach across the class and were used in both phase 2 trials.
No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.
Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.
Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.